Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
204.80
+5.04 (2.52%)
Aug 12, 2025, 11:53 AM - Market open
ROIC Employees
As of December 31, 2024, Danaher had 63,000 total employees, including 61,000 full-time and 2,000 part-time employees. The number of employees did not change compared to the previous year.
Employees
63,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$381,159
Profits / Employee
$54,175
Market Cap
146.65B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 63,000 | 0 | - |
Dec 31, 2023 | 63,000 | -18,000 | -22.22% |
Dec 31, 2022 | 81,000 | 1,000 | 1.25% |
Dec 31, 2021 | 80,000 | 11,000 | 15.94% |
Dec 31, 2020 | 69,000 | 9,000 | 15.00% |
Dec 31, 2019 | 60,000 | -11,000 | -15.49% |
Dec 31, 2018 | 71,000 | 4,000 | 5.97% |
Dec 31, 2017 | 67,000 | 5,000 | 8.06% |
Dec 31, 2016 | 62,000 | -19,000 | -23.46% |
Dec 31, 2015 | 81,000 | 10,000 | 14.08% |
Dec 31, 2014 | 71,000 | 5,000 | 7.58% |
Dec 31, 2013 | 66,000 | 3,000 | 4.76% |
Dec 31, 2012 | 63,000 | 4,000 | 6.78% |
Dec 31, 2011 | 59,000 | 10,800 | 22.41% |
Dec 31, 2010 | 48,200 | 1,600 | 3.43% |
Dec 31, 2009 | 46,600 | -3,700 | -7.36% |
Dec 31, 2008 | 50,300 | 300 | 0.60% |
Dec 31, 2007 | 50,000 | 5,000 | 11.11% |
Dec 31, 2006 | 45,000 | 5,000 | 12.50% |
Dec 31, 2005 | 40,000 | 5,000 | 14.29% |
Dec 31, 2004 | 35,000 | 5,000 | 16.67% |
Dec 31, 2003 | 30,000 | 1,000 | 3.45% |
Dec 31, 2002 | 29,000 | 6,000 | 26.09% |
Dec 31, 2001 | 23,000 | -1,000 | -4.17% |
Dec 31, 2000 | 24,000 | 5,000 | 26.32% |
Dec 31, 1999 | 19,000 | 1,000 | 5.56% |
Dec 31, 1998 | 18,000 | 4,800 | 36.36% |
Dec 31, 1997 | 13,200 | 1,600 | 13.79% |
Dec 31, 1996 | 11,600 | 1,100 | 10.48% |
Dec 31, 1995 | 10,500 | 540 | 5.42% |
Dec 31, 1994 | 9,960 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
DHR News
- 4 days ago - Analysts' Top S&P 500 Stocks to Buy Now - Kiplinger
- 8 days ago - Danaher Stock Closes Near Day's High After Key Trading Signal - Benzinga
- 11 days ago - Danaher Appoints Jonathan Leiken as General Counsel - PRNewsWire
- 18 days ago - Danaher Q2 2025 Update - Seeking Alpha
- 20 days ago - Danaher Stock: Attractively Valued And Poised For Growth Acceleration - Seeking Alpha
- 20 days ago - Danaher Corporation (DHR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Danaher lifts annual profit view on strength in diagnostics, names new CFO - Reuters
- 21 days ago - Danaher Announces Transition Plan for Chief Financial Officer - PRNewsWire